Concepedia

Norihiko Shiraishi

NS

26

Publications

2.3K

Citations

21

H-Index

1998

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Tokyo

Harvard University

Kyowa Kirin (Japan)

Fukuoka University

Norihiko Shiraishi is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cell death.

Top concepts

Publications per year

1998–2020

26

Publications

26

Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein

Shinji Ito, Satoko Kinoshita, Norihiko Shiraishi et al. · Mechanisms of Development · 2000 · 303 citations

, , +7

Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells

Aldo M. Roccaro, Teru Hideshima, Noopur Raje et al. · Cancer Research · 2006 · 284 citations

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

Noopur Raje, Shaji Kumar, Teru Hideshima et al. · Blood · 2005 · 182 citations · Full text

5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells

Tanyel Kiziltepe, Teru Hideshima, Laurence Catley et al. · Molecular Cancer Therapeutics · 2007 · 177 citations · Full text

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki et al. · Blood · 2005 · 169 citations · Full text

Rows per page

1–5 of 26